These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 1893380)
1. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells. Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380 [TBL] [Abstract][Full Text] [Related]
2. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance. Kang Y; Perry RR Cancer Res; 1993 Jul; 53(13):3040-5. PubMed ID: 8100483 [TBL] [Abstract][Full Text] [Related]
3. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods. Yang LY; Trujillo JM Cancer Res; 1990 Jun; 50(11):3218-25. PubMed ID: 2334917 [TBL] [Abstract][Full Text] [Related]
4. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787 [TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon carcinoma cells. Fanciulli M; Bruno T; Castiglione S; Del Carlo C; Paggi MG; Floridi A Oncol Res; 1993; 5(9):357-62. PubMed ID: 8038456 [TBL] [Abstract][Full Text] [Related]
6. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825 [TBL] [Abstract][Full Text] [Related]
7. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance. Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Slovak ML; Hoeltge GA; Dalton WS; Trent JM Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069 [TBL] [Abstract][Full Text] [Related]
9. Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cells. Yang LY; Trujillo JM; Su YZ Anticancer Res; 1992; 12(2):473-9. PubMed ID: 1349796 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic drug resistance in a human medullary thyroid carcinoma cell line: association with overexpression of mdrl gene and low proliferation fraction. Yang KP; Liang YF; Samaan NA Anticancer Res; 1991; 11(3):1065-8. PubMed ID: 1888139 [TBL] [Abstract][Full Text] [Related]
12. [Relationship between multidrug resistance in human colon carcinoma LoVo/Adr cell line and intracellular calcium ion concentration]. Ma Q; Zhang ZS; Zhang YL; Lai ZS Ai Zheng; 2002 Aug; 21(8):846-9. PubMed ID: 12478890 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms. Slovak ML; Coccia M; Meltzer PS; Trent JM Anticancer Res; 1991; 11(1):423-8. PubMed ID: 1673331 [TBL] [Abstract][Full Text] [Related]
14. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha. Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells. Arancia G; Calcabrini A; Marra M; Crateri P; Artico M; Martone A; Martelli F; Agostinelli E Amino Acids; 2004 Jun; 26(3):273-82. PubMed ID: 15221508 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model. Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108 [TBL] [Abstract][Full Text] [Related]
17. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells. Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228 [TBL] [Abstract][Full Text] [Related]
19. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756 [TBL] [Abstract][Full Text] [Related]
20. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]